Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 166

1.

Midostaurin in combination with intensive chemotherapy is safe and associated with improved remission rates and higher transplantation rates in first remission-a multi-center historical control study.

Berger T, Rozovski U, Moshe Y, Yaari S, Frisch A, Hellmann I, Apel A, Aviram A, Koren-Michowitz M, Yeshurun M, Ram R, Raanani P, Ofran Y, Wolach O.

Ann Hematol. 2019 Sep 11. doi: 10.1007/s00277-019-03795-8. [Epub ahead of print]

PMID:
31512015
2.

Necrotizing Hemorrhagic Gastritis following Acute Myeloid Leukemia Induction with Midostaurin: An Unexpected Complication.

Shimony S, Reiss Mintz H, Shvartser Beryozkin Y, Shoham A, Raanani P, Wolach O.

Acta Haematol. 2019 Jul 10:1-4. doi: 10.1159/000500975. [Epub ahead of print]

PMID:
31291613
3.

Venetoclax in patients with acute myeloid leukemia refractory to hypomethylating agents-a multicenter historical prospective study.

Ram R, Amit O, Zuckerman T, Gurion R, Raanani P, Bar-On Y, Avivi I, Wolach O.

Ann Hematol. 2019 Aug;98(8):1927-1932. doi: 10.1007/s00277-019-03719-6. Epub 2019 Jun 11.

PMID:
31187237
4.

Prevalence and clinical significance of hypercalcemia at diagnosis in diffuse large B-cell lymphoma.

Abadi U, Peled L, Gurion R, Rotman-Pikielny P, Raanani P, Ellis MH, Rozovski U.

Leuk Lymphoma. 2019 Jun 6:1-5. doi: 10.1080/10428194.2019.1620946. [Epub ahead of print]

PMID:
31167584
5.

Safety-Related Postmarketing Modifications of Drugs for Hematological Malignancies.

Gafter-Gvili A, Tibau A, Raanani P, Shepshelovich D.

Acta Haematol. 2019 Jun 5:1-5. doi: 10.1159/000500229. [Epub ahead of print]

PMID:
31167178
6.

The Effects of Proteasome Inhibitors on Telomerase Activity and Regulation in Multiple Myeloma Cells.

Shalem-Cohavi N, Beery E, Nordenberg J, Rozovski U, Raanani P, Lahav M, Uziel O.

Int J Mol Sci. 2019 May 21;20(10). pii: E2509. doi: 10.3390/ijms20102509.

7.

Risk factors for mortality due to Acinetobacter baumannii bacteremia in patients with hematological malignancies - a retrospective study.

Shargian-Alon L, Gafter-Gvili A, Ben-Zvi H, Wolach O, Yeshurun M, Raanani P, Yahav D.

Leuk Lymphoma. 2019 Apr 24:1-6. doi: 10.1080/10428194.2019.1599113. [Epub ahead of print]

PMID:
31014145
8.

Anthracycline-Induced Cardiotoxicity in Acute Myeloid Leukemia Patients Who Undergo Allogeneic Hematopoietic Stem Cell Transplantation.

Pasvolsky O, Morelli O, Rozovski U, Vaturi M, Wolach O, Amitai I, Vaxman I, Ratzon R, Yeshurun M, Kornowski R, Iakobishvilli Z, Raanani P.

Clin Lymphoma Myeloma Leuk. 2019 Jul;19(7):e343-e348. doi: 10.1016/j.clml.2019.03.007. Epub 2019 Mar 11.

PMID:
30948329
9.

[THROMBOCYTOPENIA, LEG EDEMA AND SHORTNESS OF BREATH FOLLOWING CORONARY ARTERY BYPASS SURGERY].

Steimatzky A, Tamir S, Raanani P, Spectre G.

Harefuah. 2019 Mar;158(3):192-195. Hebrew.

PMID:
30916509
10.

Hemophagocytic lymphohistiocytosis as a harbinger of aggressive lymphoma: a case series.

Pasvolsky O, Zoref-Lorenz A, Abadi U, Geiger KR, Hayman L, Vaxman I, Raanani P, Leader A.

Int J Hematol. 2019 May;109(5):553-562. doi: 10.1007/s12185-019-02623-z. Epub 2019 Mar 8.

PMID:
30850926
11.

Human herpes virus 6 reactivation following autologous hematopoietic cell transplantation - a single-center experience.

Shargian-Alon L, Yahav D, Rozovski U, Dovrat S, Amitai I, Sela-Navon M, Pasvolsky O, Raanani P, Yeshurun M.

Leuk Lymphoma. 2019 Feb 18:1-7. doi: 10.1080/10428194.2019.1576869. [Epub ahead of print]

PMID:
30773083
12.

FDG PET/CT as a diagnostic and prognostic tool for the evaluation of marginal zone lymphoma.

Vaxman I, Bernstine H, Kleinstern G, Hendin N, Shimony S, Domachevsky L, Gurion R, Groshar D, Raanani P, Gafter-Gvili A.

Hematol Oncol. 2019 Apr;37(2):168-175. doi: 10.1002/hon.2578. Epub 2019 Mar 18.

PMID:
30734341
13.

Reply: Letter to the Editor Regarding "Autologous Stem Cell Transplantation for Systemic Sclerosis: A Systematic Review and Meta-Analysis".

Shouval R, Furie N, Raanani P, Nagler A, Gafter-Gvili A.

Biol Blood Marrow Transplant. 2019 Mar;25(3):e114-e115. doi: 10.1016/j.bbmt.2018.12.837. Epub 2019 Jan 8. No abstract available.

PMID:
30634052
14.

Managing Anti-Platelet Therapy in Thrombocytopaenic Patients with Haematological Malignancy: A Multinational Clinical Vignette-Based Experiment.

Leader A, Ten Cate V, Ten Cate-Hoek AJ, Spectre G, Beckers EAM, Raanani P, Giaccherini C, Pereg D, Schouten HC, Falanga A, Ten Cate H.

Thromb Haemost. 2019 Jan;119(1):163-174. doi: 10.1055/s-0038-1676520. Epub 2018 Dec 31.

PMID:
30597510
15.

Dysfunctional endothelial progenitor cells in patients with Hodgkin's lymphoma in complete remission.

Wiessman M, Leshem D, Yeshurun M, Yavin H, Iakobishvilli Z, Raanani P, Kornowski R, Lev EI, Vaturi M.

Cancer Med. 2019 Jan;8(1):305-310. doi: 10.1002/cam4.1914. Epub 2018 Dec 13.

16.

Spontaneous Regression of Hodgkin Lymphoma: Case Report and Review of the Literature.

Pasvolsky O, Berger T, Bernstine H, Hayman L, Raanani P, Vidal L.

Acta Haematol. 2019;141(1):14-18. doi: 10.1159/000494422. Epub 2018 Nov 15.

PMID:
30439716
17.

Immune Mediated Cerebellar Ataxia: An Unknown Manifestation of Graft-versus-Host Disease.

Shargian-Alon L, Raanani P, Rozovski U, Siegal T, Yust-Katz S, Yeshurun M.

Acta Haematol. 2019;141(1):19-22. doi: 10.1159/000494423. Epub 2018 Nov 15.

PMID:
30439710
18.

Deferasirox selectively induces cell death in the clinically relevant population of leukemic CD34+CD38- cells through iron chelation, induction of ROS, and inhibition of HIF1α expression.

Shapira S, Raanani P, Samara A, Nagler A, Lubin I, Arber N, Granot G.

Exp Hematol. 2019 Feb;70:55-69.e4. doi: 10.1016/j.exphem.2018.10.010. Epub 2018 Nov 8.

PMID:
30414989
19.

What's New in Acta Haematologica in 2018.

Raanani P.

Acta Haematol. 2018;140(4):193. doi: 10.1159/000493570. Epub 2018 Oct 18. No abstract available.

20.

Thrombosis, anticoagulation and outcomes in malignant superior vena cava syndrome.

Ratzon R, Tamir S, Friehmann T, Livneh N, Dudnik E, Rozental A, Hamburger-Avnery O, Pereg D, Derazne E, Brenner B, Raanani P, Ten Cate H, Spectre G, Leader A.

J Thromb Thrombolysis. 2019 Jan;47(1):121-128. doi: 10.1007/s11239-018-1747-6.

PMID:
30255420
21.

The role of maintenance therapy in patients with diffuse large B cell lymphoma: A systematic review and meta-analysis.

Rozental A, Gafter-Gvili A, Vidal L, Raanani P, Gurion R.

Hematol Oncol. 2019 Feb;37(1):27-34. doi: 10.1002/hon.2561. Epub 2018 Oct 8.

PMID:
30216478
22.

Identifying Tyrosine Kinase Inhibitor Nonadherence in Chronic Myeloid Leukemia: Subanalysis of TAKE-IT Pilot Study.

Leader A, Gafter-Gvili A, Benyamini N, Dreyer J, Calvarysky B, Amitai A, Yarchovsky-Dolberg O, Sharf G, Tousset E, Caspi O, Ellis M, Levi I, Raanani P, De Geest S.

Clin Lymphoma Myeloma Leuk. 2018 Sep;18(9):e351-e362. doi: 10.1016/j.clml.2018.06.007. Epub 2018 Jun 12.

PMID:
30122203
23.

Agranulocytosis Associated with Waldenström Macroglobulinemia.

Vaxman I, Shepshelovich D, Hayman L, Raanani P, Lahav M.

Acta Haematol. 2018;140(1):42-45. doi: 10.1159/000489482. Epub 2018 Aug 16.

PMID:
30114687
24.

Effect of Adherence-enhancing Interventions on Adherence to Tyrosine Kinase Inhibitor Treatment in Chronic Myeloid Leukemia (TAKE-IT): A Quasi-experimental Pre-Post Intervention Multicenter Pilot Study.

Leader A, Benyamini N, Gafter-Gvili A, Dreyer J, Calvarysky B, Amitai A, Yarchovsky-Dolberg O, Sharf G, Tousset E, Caspi O, Ellis M, Levi I, De Geest S, Raanani P.

Clin Lymphoma Myeloma Leuk. 2018 Nov;18(11):e449-e461. doi: 10.1016/j.clml.2018.06.026. Epub 2018 Jun 25.

PMID:
30030034
25.

Utility of PET-CT for Evaluation of Patients With Peripheral T-cell Lymphoma.

Gurion R, Bernstine H, Domachevsky L, Michelson C, Raanani P, Vidal L, Shochat T, Gafter-Gvili A.

Clin Lymphoma Myeloma Leuk. 2018 Oct;18(10):687-691. doi: 10.1016/j.clml.2018.06.022. Epub 2018 Jun 27.

PMID:
30017596
26.

Can bone marrow cellularity help in predicting prognosis in myelodysplastic syndromes?

Greenbaum U, Joffe E, Filanovsky K, Oster HS, Kirgner I, Levi I, Raanani P, Avivi I, Manor E, Man-El G, Mittelman M.

Eur J Haematol. 2018 Oct;101(4):502-507. doi: 10.1111/ejh.13134. Epub 2018 Aug 31.

PMID:
29956845
27.

Hypomethylating Agents-associated Infections-Systematic Review and Meta-analysis of Randomized Controlled Trials.

Shargian-Alon L, Gurion R, Raanani P, Yahav D, Gafter-Gvili A.

Clin Lymphoma Myeloma Leuk. 2018 Sep;18(9):603-610.e1. doi: 10.1016/j.clml.2018.05.017. Epub 2018 May 28.

PMID:
29921527
28.

Real-life Experience With Ponatinib in Chronic Myeloid Leukemia: A Multicenter Observational Study.

Shacham-Abulafia A, Raanani P, Lavie D, Volchek Y, Ram R, Helman I, Shargian L, Gourevitch A, Chubar E, Ratzon R, Rozovski U.

Clin Lymphoma Myeloma Leuk. 2018 Jul;18(7):e295-e301. doi: 10.1016/j.clml.2018.05.002. Epub 2018 May 7.

PMID:
29773429
29.

Bosutinib, dasatinib, imatinib, nilotinib, and ponatinib differentially affect the vascular molecular pathways and functionality of human endothelial cells.

Gover-Proaktor A, Granot G, Pasmanik-Chor M, Pasvolsky O, Shapira S, Raz O, Raanani P, Leader A.

Leuk Lymphoma. 2019 Jan;60(1):189-199. doi: 10.1080/10428194.2018.1466294. Epub 2018 May 9.

PMID:
29741440
30.

Morbidity and mortality after fragility hip fracture surgery in patients receiving vitamin K antagonists and direct oral anticoagulants.

Frenkel Rutenberg T, Velkes S, Vitenberg M, Leader A, Halavy Y, Raanani P, Yassin M, Spectre G.

Thromb Res. 2018 Jun;166:106-112. doi: 10.1016/j.thromres.2018.04.022. Epub 2018 Apr 26.

PMID:
29727737
31.

Autologous Hematopoietic Stem Cell Transplantation for Systemic Sclerosis: A Systematic Review and Meta-Analysis.

Shouval R, Furie N, Raanani P, Nagler A, Gafter-Gvili A.

Biol Blood Marrow Transplant. 2018 May;24(5):937-944. doi: 10.1016/j.bbmt.2018.01.020. Epub 2018 Jan 31.

32.

PET-adapted therapy for advanced Hodgkin lymphoma - systematic review.

Amitai I, Gurion R, Vidal L, Dann EJ, Raanani P, Gafter-Gvili A.

Acta Oncol. 2018 Jun;57(6):765-772. doi: 10.1080/0284186X.2018.1426877. Epub 2018 Jan 18. Review.

PMID:
29345517
33.

Thalassemia Major and Intermedia in Patients Older than 35 Years: A Single Center Experience.

Shargian-Alon L, Pasvolsky O, Raanani P.

Isr Med Assoc J. 2017 Dec;19(12):767-771.

34.

Antibacterial prophylaxis with ciprofloxacin for patients with multiple myeloma and lymphoma undergoing autologous haematopoietic cell transplantation: a quasi-experimental single-centre before-after study.

Yeshurun M, Vaxman I, Shargian L, Yahav D, Bishara J, Pasvolsky O, Wolach O, Lahav M, Gurion R, Magen H, Vidal L, Herscovici C, Peck A, Moshe M, Sela-Navon M, Naparstek E, Raanani P, Rozovski U.

Clin Microbiol Infect. 2018 Jul;24(7):749-754. doi: 10.1016/j.cmi.2017.11.019. Epub 2017 Dec 6.

35.

Intravenous immunoglobulin-induced acute thrombocytopenia.

Gurevich-Shapiro A, Bonstein L, Spectre G, Atweh N, Gruenewal T, Shapiro M, Tadmor B, Raanani P.

Transfusion. 2018 Feb;58(2):493-497. doi: 10.1111/trf.14419. Epub 2017 Nov 29.

PMID:
29193103
36.

MicroRNAs as predictors for CNS relapse of systemic diffuse large B-cell lymphoma.

Pillar N, Bairey O, Goldschmidt N, Fellig Y, Rosenblat Y, Shehtman I, Haguel D, Raanani P, Shomron N, Siegal T.

Oncotarget. 2017 Sep 15;8(49):86020-86030. doi: 10.18632/oncotarget.20902. eCollection 2017 Oct 17.

37.

Treatment and prognosis of stage I follicular lymphoma in the modern era - does PET matter?

Bentur OS, Gurion R, Gafter-Gvili A, Gatt M, Shvidel L, Horowitz NA, Ram R, Herishanu Y, Sarid N, Paltiel O, Ganzel C, Kreiniz N, Dally N, Gutwein O, Raanani P, Avivi I, Perry C.

Leuk Lymphoma. 2018 May;59(5):1163-1171. doi: 10.1080/10428194.2017.1375102. Epub 2017 Sep 13.

PMID:
28901817
38.

Switching-On Adherence in Chronic Myeloid Leukemia.

Leader A, Raanani P.

Acta Haematol. 2017;138(3):138-139. doi: 10.1159/000479484. Epub 2017 Sep 6. No abstract available.

PMID:
28873366
39.

The effect of R-CHOP dose reduction on overall survival of elderly patients with DLBCL - comparative study.

Vidal L, Lando S, Vaxman I, Shochat T, Raanani P, Gurion R, Gafter-Gvili A.

Leuk Lymphoma. 2018 Apr;59(4):904-910. doi: 10.1080/10428194.2017.1365856. Epub 2017 Aug 22.

PMID:
28828883
40.

18F-FDG-PET/CT Pulmonary Infiltrates in Non-Hodgkin Lymphoma Patients Treated with Combined Immunochemotherapy: Incidence and Clinical Characteristics.

Cohen YC, Berger T, Eshel L, Stern D, Bairey O, Raanani P, Shpilberg O.

Isr Med Assoc J. 2017 Jun;19(6):372-377.

41.

[ADHERENCE TO ORAL ANTI-CANCER DRUGS IN HEMATO-ONCOLOGY].

Ashkenazi S, Dreyer J, Raanani P, Leader A.

Harefuah. 2017 Apr;156(4):254-258. Review. Hebrew.

PMID:
28551924
42.

Screening for occult cancer in idiopathic venous thromboembolism - Systemic review and meta-analysis.

Klein A, Shepshelovich D, Spectre G, Goldvaser H, Raanani P, Gafter-Gvili A.

Eur J Intern Med. 2017 Jul;42:74-80. doi: 10.1016/j.ejim.2017.05.007. Epub 2017 May 12. Review.

PMID:
28502867
43.

Concomitant Treatment with Ibrutinib and Amiodarone Causing Reversible Heart Failure Syndrome.

Wasserstrum Y, Raanani P, Kornowski R, Iakobishvili Z.

Isr Med Assoc J. 2016 Jul;18(7):433-434. No abstract available.

44.

Extended Small-Dose Platelet Transfusions in Multitransfused Hemato-Oncological Patients: A Single-Center Experience.

Gurevich-Shapiro A, Tzadok S, Rosenberg A, Inbal A, Bar-Natan M, Wolach O, Raanani P.

Acta Haematol. 2017;137(4):183-190. doi: 10.1159/000465510. Epub 2017 Apr 19.

PMID:
28419992
45.

The Effect of Combined Aspirin and Clopidogrel Treatment on Cancer Incidence.

Leader A, Zelikson-Saporta R, Pereg D, Spectre G, Rozovski U, Raanani P, Hermoni D, Lishner M.

Am J Med. 2017 Jul;130(7):826-832. doi: 10.1016/j.amjmed.2017.01.022. Epub 2017 Feb 14.

PMID:
28213047
46.

Bendamustine-associated infections-systematic review and meta-analysis of randomized controlled trials.

Gafter-Gvili A, Gurion R, Raanani P, Shpilberg O, Vidal L.

Hematol Oncol. 2017 Dec;35(4):424-431. doi: 10.1002/hon.2350. Epub 2016 Oct 13. Review.

PMID:
27734524
47.

Enteroviral infection in patients treated with rituximab for non-Hodgkin lymphoma: a case series and review of the literature.

Grisariu S, Vaxman I, Gatt M, Elias S, Avni B, Arad A, Pasvolsky O, Raanani P, Paltiel O.

Hematol Oncol. 2017 Dec;35(4):591-598. doi: 10.1002/hon.2365. Epub 2016 Oct 13. Review.

PMID:
27734521
48.

Ponatinib reduces viability, migration, and functionality of human endothelial cells.

Gover-Proaktor A, Granot G, Shapira S, Raz O, Pasvolsky O, Nagler A, Lev DL, Inbal A, Lubin I, Raanani P, Leader A.

Leuk Lymphoma. 2017 Jun;58(6):1455-1467. doi: 10.1080/10428194.2016.1239258. Epub 2016 Oct 12.

PMID:
27733071
49.

First line treatment with newer tyrosine kinase inhibitors in chronic myeloid leukemia associated with deep and durable molecular response - systematic review and meta-analysis.

Gurion R, Raanani P, Vidal L, Leader A, Gafter-Gvili A.

Acta Oncol. 2016 Sep - Oct;55(9-10):1077-1083. doi: 10.1080/0284186X.2016.1201214. Epub 2016 Aug 25. Review.

PMID:
27560448
50.

Azacitidine-lenalidomide (ViLen) combination yields a high response rate in higher risk myelodysplastic syndromes (MDS)-ViLen-01 protocol.

Mittelman M, Filanovsky K, Ofran Y, Rosenbaum H, Raanani P, Braester A, Goldschmidt N, Kirgner I, Herishanu Y, Perri C, Ellis M, Oster HS; Israel Myelodysplastic Syndrome Working Group (MDS-WG).

Ann Hematol. 2016 Oct;95(11):1811-8. doi: 10.1007/s00277-016-2776-x. Epub 2016 Aug 22.

PMID:
27546027

Supplemental Content

Loading ...
Support Center